Isolated Plasmacytoma of Bone: Clinical Trials

8 trials for Isolated Plasmacytoma of Bone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting. 3 Phase 1, 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Not applicable2Completed 2
Phase 22Completed 2

Follow Isolated Plasmacytoma of Bone: new trials by email Literature Review of Isolated Plasmacytoma of Bone trials Research Report on Isolated Plasmacytoma of Bone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
dexamethasone, cisplatin, doxorubicin - Extramedullary Plasmacytoma, Isolated Plasmacytoma of Bone
Phase 2CompletedMargarida Magalhaes-Silverman412013-04-042022-05-11
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedCity of Hope Medical Center362012-10-292024-04-02
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
infection prophylaxis and management, laboratory biomarker analysis, flow cytometry - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active not recruitingCity of Hope Medical Center1532011-01-112026-10-22
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedWake Forest University Health Sciences802010-04-012018-07-02
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 1CompletedNational Cancer Institute (NCI)422009-08-012014-03-17
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Phase 1CompletedNational Cancer Institute (NCI)602001-08-012013-02-07
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center51999-11-012017-05-24

Narrower conditions

Multiple Myeloma (8)  ·  Burkitt Lymphoma (7)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (7)  ·  Leukemia, Myeloid, Accelerated Phase (7)  ·  Leukemia, Myeloid, Chronic-Phase (7)  ·  Leukemia, Myelomonocytic, Chronic (7)  ·  Lymphoma, Large B-Cell, Diffuse (7)  ·  Lymphoma, T-Cell, Cutaneous (7)  ·  Mycosis Fungoides (7)  ·  Pdgfra-Associated Chronic Eosinophilic Leukemia (7)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (7)  ·  Primary Myelofibrosis (7)  ·  Sezary Syndrome (7)  ·  Thrombocythemia, Essential (7)  ·  Hodgkin Disease (6)

Broader conditions

Blood Protein Disorders (8)  ·  Cardiovascular Diseases (8)  ·  Hematologic Diseases (8)  ·  Hemic and Lymphatic Diseases (8)  ·  Hemorrhagic Disorders (8)  ·  Hemostatic Disorders (8)  ·  Immune System Diseases (8)  ·  Immunoproliferative Disorders (8)  ·  Lymphoproliferative Disorders (8)  ·  Neoplasms (8)  ·  Neoplasms by Histologic Type (8)  ·  Paraproteinemias (8)  ·  Vascular Diseases (8)  ·  Blood Coagulation Disorders (7)  ·  Blood Platelet Disorders (7)

Interventions

Antiviral Agents (1)  ·  Beclomethasone (1)  ·  Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Flow Cytometry (1)  ·  Foscarnet (1)  ·  Ganciclovir (1)  ·  Imatinib Mesylate (1)  ·  Massage (1)

Sponsors

City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  National Cancer Institute (NCI) (2)  ·  Margarida Magalhaes-Silverman (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (8)

Top investigators

Ryotaro Nakamura (2)  ·  Ann Woolfrey (1)  ·  Janet Tooze, PhD (1)  ·  John Deeken (1)  ·  Margarida Magalhaes-Silverman, MD (1)  ·  Paul Martin (1)  ·  Ramesh Ramanathan (1)

Results publications

PMID 18698002, PMID 22259028, PMID 24474568, PMID 26853648, PMID 30562587

NIH funding

P01CA018029 (1), P30CA015704 (1), P30CA086862 (1), U01CA062487 (1), U01CA062491 (1), U01CA062502 (1), U01CA062505 (1), U01CA099168 (1), U01CA121947 (1)